Literature DB >> 21354149

S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells.

Lissbeth Leon-Bollotte1, Selvakumar Subramaniam, Olivier Cauvard, Stéphanie Plenchette-Colas, Catherine Paul, Cindy Godard, Antonio Martinez-Ruiz, Patrick Legembre, Jean-François Jeannin, Ali Bettaieb.   

Abstract

BACKGROUND & AIMS: Fas belongs to the family of tumor necrosis factor receptors which induce apoptosis. Many cancer cells express Fas but do not undergo Fas-mediated apoptosis. Nitric oxide reverses this resistance by increasing levels of Fas at the plasma membrane. We studied the mechanisms by which NO affects Fas function.
METHODS: Colon and mammary cancer cell lines were incubated with the NO donor glyceryl trinitrate or lipid A; S-nitrosylation of Fas was monitored using the biotin switch assay. Fas constructs that contained mutations at cysteine residues that prevent S-nitrosylation were used to investigate the involvement of S-nitrosylation in Fas-mediated cell death. Apoptosis was monitored according to morphologic criteria.
RESULTS: NO induced S-nitrosylation of cysteine residues 199 and 304 in the cytoplasmic part of Fas. In cancer cells that overexpressed wild-type Fas, S-nitrosylation induced Fas recruitment to lipid rafts and sensitized the cells to Fas ligand. In cells that expressed a mutant form of Fas in which cysteine 304 was replaced by valine residue, NO-mediated translocation of Fas to lipid rafts was affected and the death-inducing signal complex and synergistic effect of glyceryl trinitrate-Fas ligand were inhibited significantly. These effects were not observed in cells that expressed Fas with a mutation at cysteine 199.
CONCLUSIONS: We identified post-translational modifications (S-nitrosylation of cysteine residues 199 and 304) in the cytoplasmic domain of Fas. S-nitrosylation at cysteine 304 promotes redistribution of Fas to lipid rafts, formation of the death-inducing signal complex, and induction of cell death.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354149     DOI: 10.1053/j.gastro.2011.02.053

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  33 in total

Review 1.  Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target.

Authors:  Elizabeth A Grimm; Andrew G Sikora; Suhendan Ekmekcioglu
Journal:  Clin Cancer Res       Date:  2013-07-18       Impact factor: 12.531

2.  Apoptosis of bladder transitional cell carcinoma T24 cells induced by adenovirus-mediated inducible nitric oxide synthase gene transfection.

Authors:  Jing Tan; Qing Zeng; Xian-Zheng Jiang; Le-Ye He; Jin-Rong Wang; Kun Yao; Chang-Hui Wang
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

Review 3.  Nitrosothiol signaling and protein nitrosation in cell death.

Authors:  Anand Krishnan V Iyer; Yon Rojanasakul; Neelam Azad
Journal:  Nitric Oxide       Date:  2014-07-23       Impact factor: 4.427

4.  Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability.

Authors:  A Rossin; J Durivault; T Chakhtoura-Feghali; N Lounnas; L Gagnoux-Palacios; A-O Hueber
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

Review 5.  Immunology Comes Full Circle in Melanoma While Specific Immunity Is Unleashed to Eliminate Metastatic Disease, Inflammatory Products of Innate Immunity Promote Resistance.

Authors:  Elizabeth A Grimm
Journal:  Crit Rev Oncog       Date:  2016

Review 6.  CD95-mediated cell signaling in cancer: mutations and post-translational modulations.

Authors:  Sébastien Tauzin; Laure Debure; Jean-François Moreau; Patrick Legembre
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

Review 7.  Innate immune cells in breast cancer--from villains to heroes?

Authors:  Tim Kees; Mikala Egeblad
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-07-26       Impact factor: 2.673

8.  Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.

Authors:  Á J De la Rosa; Á Rodríguez-Hernández; R González; S Romero-Brufau; E Navarro-Villarán; L Barrera-Pulido; S Pereira; L M Marín; F López-Bernal; J M Álamo; M A Gómez-Bravo; F J Padillo; J Muntané
Journal:  Gene Ther       Date:  2015-07-23       Impact factor: 5.250

Review 9.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

10.  The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation.

Authors:  Ahlam A Ali; Jonathan A Coulter; Claire H Ogle; Marie M Migaud; David G Hirst; Tracy Robson; Helen O McCarthy
Journal:  Biosci Rep       Date:  2013-03-28       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.